DurAct (bromfenac) Disease Interactions
There are 3 disease interactions with DurAct (bromfenac):
NSAIDs (applies to DurAct) heart failure
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Congestive Heart Failure
Fluid retention and edema have been observed in patients treated with NSAIDs, including some topical formulations. These drugs should be used with caution in patients with fluid retention or heart failure.
NSAIDs (applies to DurAct) hyperkalemia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Increase in serum potassium concentration, including hyperkalemia, have been reported with use of NSAIDs, even in some patients without renal impairment. In patients with normal renal function, these effects have been attributed to a hyporeninemic- hypoaldosteronism state.
NSAIDs (applies to DurAct) hypertension
Moderate Potential Hazard, Moderate plausibility.
NSAIDs including topicals can lead to the onset of new hypertension or worsening of preexisting hypertension, either of which can contribute to the increased incidence of cardiovascular events. Blood pressure should be monitored closely during NSAID therapy and throughout the course of therapy.
DurAct (bromfenac) drug interactions
There are 318 drug interactions with DurAct (bromfenac)
DurAct (bromfenac) alcohol/food interactions
There are 2 alcohol/food interactions with DurAct (bromfenac)
More about DurAct (bromfenac)
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.